Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spermine | 12 | 2023 | 64 | 3.580 |
Why?
|
| Retina | 23 | 2018 | 255 | 3.400 |
Why?
|
| Astrocytes | 11 | 2022 | 203 | 3.010 |
Why?
|
| Neuroglia | 21 | 2022 | 117 | 2.870 |
Why?
|
| Polyamines | 7 | 2023 | 28 | 2.860 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 15 | 2020 | 58 | 2.310 |
Why?
|
| Potassium Channels | 17 | 2010 | 73 | 1.710 |
Why?
|
| Connexin 43 | 4 | 2021 | 36 | 1.590 |
Why?
|
| Potassium | 14 | 2015 | 110 | 1.250 |
Why?
|
| Membrane Potentials | 18 | 2015 | 213 | 1.210 |
Why?
|
| Gap Junctions | 4 | 2022 | 37 | 1.010 |
Why?
|
| Spermidine | 6 | 2023 | 31 | 0.970 |
Why?
|
| Alligators and Crocodiles | 3 | 2018 | 8 | 0.960 |
Why?
|
| Cell Communication | 2 | 2015 | 93 | 0.930 |
Why?
|
| Vision, Ocular | 3 | 2018 | 40 | 0.850 |
Why?
|
| Night Vision | 2 | 2018 | 3 | 0.830 |
Why?
|
| Biological Transport | 2 | 2021 | 175 | 0.820 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 4 | 2015 | 14 | 0.790 |
Why?
|
| Animals | 48 | 2022 | 14307 | 0.750 |
Why?
|
| Light | 2 | 2018 | 180 | 0.680 |
Why?
|
| Rana pipiens | 10 | 2008 | 58 | 0.640 |
Why?
|
| Rats | 18 | 2022 | 3261 | 0.630 |
Why?
|
| Cell Membrane | 8 | 2015 | 360 | 0.600 |
Why?
|
| Neurons | 8 | 2023 | 1130 | 0.570 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2018 | 32 | 0.520 |
Why?
|
| Brain Diseases | 1 | 2014 | 33 | 0.510 |
Why?
|
| Cells, Cultured | 13 | 2020 | 1442 | 0.500 |
Why?
|
| Ion Channel Gating | 8 | 2014 | 81 | 0.460 |
Why?
|
| Patch-Clamp Techniques | 16 | 2015 | 214 | 0.410 |
Why?
|
| Brain | 4 | 2023 | 1268 | 0.410 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2010 | 12 | 0.380 |
Why?
|
| Hydrogen-Ion Concentration | 8 | 2017 | 342 | 0.380 |
Why?
|
| Quinolines | 1 | 2010 | 60 | 0.370 |
Why?
|
| Stress, Psychological | 1 | 2014 | 541 | 0.340 |
Why?
|
| Giant Cells | 2 | 2022 | 13 | 0.340 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2020 | 1534 | 0.330 |
Why?
|
| HIV Infections | 1 | 2021 | 2207 | 0.310 |
Why?
|
| Putrescine | 3 | 2022 | 25 | 0.300 |
Why?
|
| Nerve Tissue Proteins | 3 | 2014 | 338 | 0.300 |
Why?
|
| Glucose | 2 | 2020 | 217 | 0.290 |
Why?
|
| Electrophysiology | 5 | 2008 | 130 | 0.240 |
Why?
|
| Immunohistochemistry | 5 | 2006 | 859 | 0.240 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 968 | 0.240 |
Why?
|
| Glioma | 2 | 2015 | 76 | 0.230 |
Why?
|
| Glutamic Acid | 3 | 2015 | 115 | 0.220 |
Why?
|
| Brain Neoplasms | 2 | 2015 | 105 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 1530 | 0.220 |
Why?
|
| Fluorescent Dyes | 2 | 2014 | 173 | 0.220 |
Why?
|
| Ranidae | 1 | 2002 | 10 | 0.220 |
Why?
|
| Mice | 9 | 2021 | 5668 | 0.210 |
Why?
|
| Larva | 1 | 2002 | 117 | 0.210 |
Why?
|
| Electroencephalography | 1 | 2022 | 108 | 0.200 |
Why?
|
| Calcium Channels | 3 | 2000 | 72 | 0.200 |
Why?
|
| Eye Proteins | 2 | 2018 | 46 | 0.200 |
Why?
|
| Homeostasis | 5 | 2015 | 172 | 0.200 |
Why?
|
| Eflornithine | 1 | 2020 | 18 | 0.190 |
Why?
|
| Up-Regulation | 3 | 2018 | 490 | 0.190 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 210 | 0.180 |
Why?
|
| Electric Conductivity | 2 | 2015 | 47 | 0.180 |
Why?
|
| Protein Transport | 1 | 2020 | 286 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2020 | 53 | 0.180 |
Why?
|
| Calcium | 5 | 2017 | 445 | 0.180 |
Why?
|
| Ion Channels | 2 | 2015 | 69 | 0.170 |
Why?
|
| Seizures | 3 | 2022 | 67 | 0.170 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2018 | 7 | 0.170 |
Why?
|
| Adaptation, Ocular | 1 | 2018 | 11 | 0.170 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2018 | 12 | 0.170 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2018 | 28 | 0.160 |
Why?
|
| Signal Transduction | 3 | 2015 | 1802 | 0.160 |
Why?
|
| Staining and Labeling | 2 | 2012 | 100 | 0.150 |
Why?
|
| Oocytes | 3 | 2013 | 143 | 0.150 |
Why?
|
| Rats, Long-Evans | 2 | 2008 | 86 | 0.150 |
Why?
|
| Nerve Crush | 1 | 1996 | 4 | 0.140 |
Why?
|
| Optic Nerve | 1 | 1996 | 28 | 0.140 |
Why?
|
| Brain Ischemia | 1 | 2018 | 179 | 0.140 |
Why?
|
| Sweetening Agents | 1 | 2015 | 12 | 0.140 |
Why?
|
| HIV-1 | 1 | 2021 | 678 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 383 | 0.140 |
Why?
|
| Ouabain | 2 | 2013 | 15 | 0.140 |
Why?
|
| Mutation, Missense | 1 | 2016 | 80 | 0.140 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2015 | 13 | 0.140 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 20 | 0.130 |
Why?
|
| Quinine | 1 | 2014 | 10 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2020 | 386 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1149 | 0.130 |
Why?
|
| Stroke | 1 | 2018 | 274 | 0.130 |
Why?
|
| Glutamates | 1 | 2014 | 21 | 0.130 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 123 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 638 | 0.120 |
Why?
|
| Hela Cells | 1 | 2015 | 344 | 0.120 |
Why?
|
| Guinea Pigs | 5 | 2007 | 141 | 0.120 |
Why?
|
| Cell Line | 2 | 2015 | 1289 | 0.120 |
Why?
|
| Microglia | 1 | 2015 | 152 | 0.120 |
Why?
|
| Cerebral Cortex | 2 | 2013 | 274 | 0.120 |
Why?
|
| Kainic Acid | 1 | 2013 | 47 | 0.120 |
Why?
|
| Organic Cation Transporter 1 | 1 | 2013 | 2 | 0.120 |
Why?
|
| Octamer Transcription Factor-2 | 1 | 2013 | 7 | 0.120 |
Why?
|
| Humans | 17 | 2017 | 34853 | 0.120 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2013 | 18 | 0.120 |
Why?
|
| Receptors, AMPA | 1 | 2013 | 54 | 0.110 |
Why?
|
| Intracellular Fluid | 1 | 2012 | 26 | 0.110 |
Why?
|
| Carbenoxolone | 1 | 2012 | 10 | 0.110 |
Why?
|
| Pyridinium Compounds | 1 | 2012 | 21 | 0.110 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2012 | 34 | 0.110 |
Why?
|
| Isoquinolines | 1 | 2012 | 40 | 0.110 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 2 | 2011 | 21 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2014 | 304 | 0.110 |
Why?
|
| Extracellular Space | 3 | 2002 | 33 | 0.110 |
Why?
|
| Cocaine | 1 | 2014 | 219 | 0.110 |
Why?
|
| Receptors, Drug | 2 | 2002 | 56 | 0.100 |
Why?
|
| Female | 6 | 2018 | 19873 | 0.100 |
Why?
|
| Male | 9 | 2018 | 18870 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2002 | 82 | 0.100 |
Why?
|
| Rabbits | 5 | 2004 | 278 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2013 | 420 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 31 | 0.100 |
Why?
|
| Fluorescence | 1 | 2010 | 117 | 0.090 |
Why?
|
| Huntington Disease | 1 | 2008 | 25 | 0.080 |
Why?
|
| Mutation | 2 | 2010 | 1023 | 0.080 |
Why?
|
| Potassium Channel Blockers | 2 | 2006 | 30 | 0.080 |
Why?
|
| DNA, Mitochondrial | 1 | 2008 | 165 | 0.080 |
Why?
|
| Vertebrates | 1 | 2007 | 29 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2022 | 70 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 1300 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 485 | 0.070 |
Why?
|
| Xenopus laevis | 3 | 2013 | 73 | 0.070 |
Why?
|
| Retinal Diseases | 1 | 2006 | 17 | 0.070 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2006 | 27 | 0.070 |
Why?
|
| Perfusion | 1 | 2006 | 31 | 0.070 |
Why?
|
| Osmotic Pressure | 1 | 2006 | 20 | 0.070 |
Why?
|
| DNA Damage | 1 | 2008 | 341 | 0.070 |
Why?
|
| Cell Size | 1 | 2006 | 42 | 0.070 |
Why?
|
| Rats, Wistar | 3 | 2013 | 202 | 0.070 |
Why?
|
| Ion Transport | 3 | 2000 | 15 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 2128 | 0.070 |
Why?
|
| Receptors, Nicotinic | 1 | 2006 | 91 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1152 | 0.060 |
Why?
|
| Cations | 2 | 2013 | 44 | 0.060 |
Why?
|
| Tissue Distribution | 2 | 2002 | 197 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 122 | 0.060 |
Why?
|
| Tolbutamide | 1 | 2002 | 4 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2022 | 34 | 0.050 |
Why?
|
| Rana catesbeiana | 1 | 2002 | 27 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2002 | 54 | 0.050 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2001 | 5 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2001 | 75 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2002 | 180 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2022 | 130 | 0.050 |
Why?
|
| Farnesol | 1 | 2000 | 3 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 152 | 0.050 |
Why?
|
| Bufo marinus | 1 | 2000 | 6 | 0.050 |
Why?
|
| Anura | 1 | 2000 | 29 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 608 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 283 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 984 | 0.050 |
Why?
|
| Vitreous Body | 1 | 1999 | 11 | 0.050 |
Why?
|
| Cell Polarity | 1 | 1999 | 53 | 0.040 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 1999 | 8 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 1998 | 32 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 396 | 0.040 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2018 | 30 | 0.040 |
Why?
|
| Cell Count | 1 | 2018 | 129 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2018 | 186 | 0.040 |
Why?
|
| Transfection | 2 | 2010 | 496 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 2017 | 12 | 0.040 |
Why?
|
| Time Factors | 2 | 2015 | 1681 | 0.040 |
Why?
|
| Acidosis | 1 | 2017 | 49 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 1124 | 0.040 |
Why?
|
| Neocortex | 1 | 2015 | 26 | 0.030 |
Why?
|
| Biophysics | 1 | 2015 | 36 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 1490 | 0.030 |
Why?
|
| Colorimetry | 1 | 2015 | 40 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2015 | 63 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 66 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2014 | 45 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 161 | 0.030 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2015 | 76 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 323 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2014 | 171 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 247 | 0.030 |
Why?
|
| Locomotion | 1 | 2014 | 91 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 528 | 0.030 |
Why?
|
| Adamantane | 1 | 2013 | 8 | 0.030 |
Why?
|
| Dopamine | 1 | 2014 | 232 | 0.030 |
Why?
|
| Piperidines | 1 | 2013 | 76 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 2012 | 30 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 101 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2013 | 186 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 237 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2013 | 95 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 240 | 0.030 |
Why?
|
| Cell Movement | 1 | 2015 | 545 | 0.030 |
Why?
|
| Cricetulus | 1 | 2011 | 74 | 0.020 |
Why?
|
| CHO Cells | 1 | 2011 | 107 | 0.020 |
Why?
|
| Channelopathies | 1 | 2010 | 5 | 0.020 |
Why?
|
| Ataxia | 1 | 2010 | 8 | 0.020 |
Why?
|
| Barium | 1 | 2010 | 15 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2010 | 7 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 217 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 72 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 69 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 249 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 97 | 0.020 |
Why?
|
| Propionates | 1 | 2008 | 25 | 0.020 |
Why?
|
| Synaptic Transmission | 2 | 2002 | 141 | 0.020 |
Why?
|
| Guanosine | 1 | 2008 | 27 | 0.020 |
Why?
|
| Nitro Compounds | 1 | 2008 | 32 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 1503 | 0.020 |
Why?
|
| Refraction, Ocular | 1 | 2007 | 28 | 0.020 |
Why?
|
| COS Cells | 1 | 2007 | 62 | 0.020 |
Why?
|
| Cell Shape | 1 | 2007 | 35 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 528 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 85 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 49 | 0.020 |
Why?
|
| Lasers | 1 | 2007 | 62 | 0.020 |
Why?
|
| Tyrosine | 1 | 2007 | 109 | 0.020 |
Why?
|
| Hippocampus | 1 | 2010 | 546 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 751 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2008 | 351 | 0.020 |
Why?
|
| Dansyl Compounds | 1 | 2006 | 7 | 0.020 |
Why?
|
| Torpedo | 1 | 2006 | 41 | 0.020 |
Why?
|
| Erythrocyte Membrane | 1 | 2006 | 20 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2006 | 31 | 0.020 |
Why?
|
| Sheep | 1 | 2006 | 70 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2006 | 68 | 0.020 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2006 | 60 | 0.020 |
Why?
|
| Nicotinic Agonists | 1 | 2006 | 68 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2006 | 196 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2007 | 878 | 0.020 |
Why?
|
| Cell Survival | 1 | 2007 | 818 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 257 | 0.020 |
Why?
|
| Nicotine | 1 | 2006 | 238 | 0.010 |
Why?
|
| Blood-Retinal Barrier | 1 | 2000 | 8 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2000 | 56 | 0.010 |
Why?
|
| Free Radicals | 1 | 2000 | 72 | 0.010 |
Why?
|
| Sodium Channels | 1 | 2000 | 63 | 0.010 |
Why?
|
| Reaction Time | 1 | 2000 | 130 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2000 | 57 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2000 | 160 | 0.010 |
Why?
|
| Tetraethylammonium | 1 | 1999 | 6 | 0.010 |
Why?
|
| 4-Aminopyridine | 1 | 1999 | 7 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1999 | 22 | 0.010 |
Why?
|
| Ornithine Decarboxylase | 1 | 1998 | 10 | 0.010 |
Why?
|
| Solutions | 1 | 1998 | 60 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1998 | 48 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 57 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1998 | 177 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1998 | 110 | 0.010 |
Why?
|
| Magnesium | 1 | 1998 | 95 | 0.010 |
Why?
|
| Swine | 1 | 1998 | 182 | 0.010 |
Why?
|
| Cell Division | 1 | 1997 | 296 | 0.010 |
Why?
|
| Adolescent | 1 | 1998 | 5035 | 0.000 |
Why?
|